In the BioHarmony Drug Report Database
Nonacog alfa
BeneFIX (nonacog alfa) is a protein pharmaceutical. Nonacog alfa was first approved as BeneFIX on 1997-08-27. It is used to treat factor VII deficiency, hemophilia a, hemophilia b, and hypoprothrombinemias in the USA. It has been approved in Europe to treat hemophilia b.
Trade Name
|
BeneFIX |
|---|---|
Common Name
|
nonacog alfa |
ChEMBL ID
|
CHEMBL2109205 |
Indication
|
factor vii deficiency, hemophilia a, hemophilia b, hypoprothrombinemias |
Drug Class
|
Image (chem structure or protein)
